Indian Drug Makers Wary Of Move To Global Customs Standards
This article was originally published in PharmAsia News
Executive Summary
Pharmaceutical companies in India are concerned about a government effort to develop global standards for national customs departments. Some pharmaceutical companies fear one proposal under consideration could create a non-tariff situation for their wares in developing countries. The groups say a proposal under consideration for the World Customs Organisation would exceed current minimum standards of global authorities on intellectual property in judging counterfeit goods by having a negative impact on generic versions of drugs. (Click here for more